Literature DB >> 29475911

Tumor Necrosis Factor-Alpha (TNF-α-308 G>A) Polymorphism in High-grade Gliomas.

Selçuk Ozdogan1, Cumhur Kaan Yaltirik2, Seda Gulec Yilmaz3, Mustafa Kaya4, Ali Haluk Duzkalir5, Nail Demirel1, Ali Kafadar6, Turgay Isbir7.   

Abstract

BACKGROUND/AIM: High-grade gliomas (HGG) consist of anaplastic oligoastrocytomas, anaplastic oligodendrogliomas, anaplastic astrocytomas and glioblastoma multiforme. The present study aimed to evaluate TNF-α -308 G>A polymorphism in a Turkish population. PATIENTS AND METHODS: This was a prospective case-control study that included 45 patients with HGG and 49 healthy individuals. All patients were operated for intracranial tumors and the pathology results consist of high grade (Grade3 and 4) glial tumors.
RESULTS: No significant differences were found between the HGG and control groups in terms of the median age (p=0.898). There were no significant differences with regard to gender (p=0.577). The TNF genotype frequency comparison between patients and controls was not statistically significant (p=0.598).
CONCLUSION: TNF genotype frequency comparison between the patients and controls was not statistically significant in the Turkish population tested. However, further studies are needed to evaluate the genotype and phenotype correlations in large cohorts of various ethnicities. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Tumor necrosis factor; high-grade gliomas; polymorphism

Mesh:

Substances:

Year:  2018        PMID: 29475911      PMCID: PMC5905196          DOI: 10.21873/invivo.11236

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  17 in total

Review 1.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 2.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

3.  Tumor necrosis factor microsatellite polymorphisms in Italian glioblastoma patients.

Authors:  S Frigerio; E Ciusani; A Pozzi; A Silvani; A Salmaggi; A Boiardi
Journal:  Cancer Genet Cytogenet       Date:  1999-03

4.  Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas.

Authors:  E Roussel; M C Gingras; E A Grimm; J M Bruner; R P Moser
Journal:  Clin Exp Immunol       Date:  1996-08       Impact factor: 4.330

5.  Radiosurgical boost for primary high-grade gliomas.

Authors:  Flavio E Prisco; Eduardo Weltman; Rodrigo M de Hanriot; Reynaldo A Brandt
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

6.  Tumor necrosis factor microsatellites in four European populations.

Authors:  B Crouau-Roy; L Briant; C Bouissou; C Stravropoulos; F Pociot; A Cambon-Thomsen; J Clayton
Journal:  Hum Immunol       Date:  1993-11       Impact factor: 2.850

7.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus.

Authors:  F Pociot; L Briant; C V Jongeneel; J Mölvig; H Worsaae; M Abbal; M Thomsen; J Nerup; A Cambon-Thomsen
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

8.  Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

Authors:  Mathilde C M Kouwenhoven; Thierry Gorlia; Johan M Kros; Ahmed Ibdaih; Alba A Brandes; Jacolien E C Bromberg; Karima Mokhtari; Sjoerd G van Duinen; Johannes L Teepen; Pieter Wesseling; Fanny Vandenbos; Wolfgang Grisold; László Sipos; Rene Mirimanoff; Charles J Vecht; Anouk Allgeier; Denis Lacombe; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

9.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

Review 10.  Survival and complications of stereotactic radiosurgery: A systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas.

Authors:  Kaleigh Fetcko; Rimas V Lukas; Gordon A Watson; Lingjiao Zhang; Mahua Dey
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.